Uniphar (DUB:UPR) Accumulated Depreciation: €-121 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DUB:UPR Uniphar PLC DUB:UPR
71 GF Score
Price €4.30
GF Value €3.68
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Uniphar Accumulated Depreciation?

Uniphar DUB:UPR -0.70% 71 Accumulated Depreciation is €-121 Mil as of Dec. 2025. GuruFocus rates DUB:UPR with a GF Score™ of 71/100 and a GF Value™ of €3.68 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Uniphar's quarterly accumulated depreciation increased from Dec. 2024 (€-102 Mil) to Jun. 2025 (€-112 Mil) and increased from Jun. 2025 (€-112 Mil) to Dec. 2025 (€-121 Mil).

Uniphar's annual accumulated depreciation increased from Dec. 2023 (€-97 Mil) to Dec. 2024 (€-102 Mil) and increased from Dec. 2024 (€-102 Mil) to Dec. 2025 (€-121 Mil).

Uniphar Accumulated Depreciation Related Terms

Uniphar Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Uniphar's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Accumulated Depreciation Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60.48 -74.22 -96.54 -102.24 -120.70

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -96.54 -106.24 -102.24 -111.81 -120.70
DUB:UPR
71GF Score
Uniphar PLC DUB:UPR
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of €-121 Mil mean?
Uniphar (DUB:UPR) has a Accumulated Depreciation of €-121 Mil as of Dec. 2025. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Uniphar and its competitors.
Is Uniphar's Accumulated Depreciation too high?
Uniphar's current Accumulated Depreciation is €-121 Mil. Overall, Uniphar has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Accumulated Depreciation compare to MCK and COR?
Uniphar's Accumulated Depreciation of €-121 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Distribution company?
A good Accumulated Depreciation depends on the Medical Distribution industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Uniphar and its competitors. Uniphar's current Accumulated Depreciation is €-121 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.68, compared to a current price of €4.30 — trading 16.8% above its estimated fair value. The current Accumulated Depreciation is €-121 Mil. Uniphar's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current Accumulated Depreciation is €-121 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (DUB:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of €4.30 is trading 16.8% above its estimated GF Value™ of €3.68. GuruFocus considers Uniphar to be Modestly Overvalued.

Key valuation signals for DUB:UPR:

  • Accumulated Depreciation: €-121 Mil
  • GF Value™: €3.68 vs. price of €4.30 (16.8% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Uniphar Business Description

Other Exchanges UPR:UK0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
71GF Score

Get the complete analysis for DUB:UPR

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.30
Price
€3.68
GF Value